Humira (adalimumab) is a prescription drug that’s used to treat certain types of arthritis and other inflammation-related diseases. It comes as a liquid solution for injection under your skin. Humira ...

Despite losing patent protection for Humira in 2016, ABBV was able to maintain the drug's market share by engaging in extensive patent litigation and agreements delaying biosimilar rollouts. These ...